ZBTB12
gene geneOn this page
Also known as G10NG35D6S59E
Summary
ZBTB12 (zinc finger and BTB domain containing 12, HGNC:19066) is a protein-coding gene on chromosome 6p21.33, encoding Zinc finger and BTB domain-containing protein 12 (Q9Y330). May be involved in transcriptional regulation.
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II; regulation of cytokine production; and regulation of immune system process. Located in nucleoplasm.
Source: NCBI Gene 221527 — RefSeq curated summary.
At a glance
- GWAS associations: 27
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_181842
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19066 |
| Approved symbol | ZBTB12 |
| Name | zinc finger and BTB domain containing 12 |
| Location | 6p21.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | G10, NG35, D6S59E |
| Ensembl gene | ENSG00000204366 |
| Ensembl biotype | protein_coding |
| Entrez | 221527 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000375527
RefSeq mRNA: 1 — MANE Select: NM_181842
NM_181842
CCDS: CCDS4727
Canonical transcript exons
ENST00000375525 — 0 exons
Expression profiles
Bgee: expression breadth ubiquitous, 129 present calls, max score 91.54.
FANTOM5 (CAGE): breadth broad, TPM avg 1.8137 / max 35.0212, expressed in 775 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 72862 | 1.8137 | 775 |
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 91.54 | gold quality |
| ganglionic eminence | UBERON:0004023 | 88.35 | gold quality |
| ventricular zone | UBERON:0003053 | 87.21 | gold quality |
| stromal cell of endometrium | CL:0002255 | 76.95 | gold quality |
| right ovary | UBERON:0002118 | 74.11 | gold quality |
| ovary | UBERON:0000992 | 74.09 | gold quality |
| body of uterus | UBERON:0009853 | 73.84 | gold quality |
| left ovary | UBERON:0002119 | 73.34 | gold quality |
| endocervix | UBERON:0000458 | 73.16 | gold quality |
| myometrium | UBERON:0001296 | 73.09 | gold quality |
| ectocervix | UBERON:0012249 | 72.06 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 71.79 | gold quality |
| right uterine tube | UBERON:0001302 | 71.71 | gold quality |
| urinary bladder | UBERON:0001255 | 71.52 | gold quality |
| uterine cervix | UBERON:0000002 | 71.42 | gold quality |
| right adrenal gland | UBERON:0001233 | 71.39 | gold quality |
| temporal lobe | UBERON:0001871 | 71.36 | gold quality |
| fallopian tube | UBERON:0003889 | 71.22 | gold quality |
| amygdala | UBERON:0001876 | 71.16 | gold quality |
| endometrium | UBERON:0001295 | 70.73 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 70.67 | gold quality |
| substantia nigra | UBERON:0002038 | 70.63 | gold quality |
| Ammon’s horn | UBERON:0001954 | 70.62 | gold quality |
| left uterine tube | UBERON:0001303 | 70.39 | gold quality |
| putamen | UBERON:0001874 | 69.85 | gold quality |
| left adrenal gland | UBERON:0001234 | 69.70 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 69.56 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 69.32 | gold quality |
| duodenum | UBERON:0002114 | 69.24 | gold quality |
| hypothalamus | UBERON:0001898 | 69.11 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.06 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
2 targets.
| Target | Regulation |
|---|---|
| FN1 | |
| THEG |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1649.1 | ZBTB12 | More than 3 adjacent zinc fingers |
| MA1649.2 | ZBTB12 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:19443739
miRNA regulators (miRDB)
7 targeting ZBTB12, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-6832-3P | 99.52 | 70.44 | 1726 |
| HSA-MIR-642A-5P | 99.51 | 65.10 | 1152 |
| HSA-MIR-4325 | 99.49 | 72.20 | 1342 |
| HSA-MIR-3664-3P | 97.85 | 67.62 | 1452 |
| HSA-MIR-7703 | 97.64 | 67.00 | 965 |
Literature-anchored findings (GeneRIF, showing 3)
- Single nucleotide polymorphisms at C6orf48, BAT2 and ZBTB12 are associated with estrogen receptor positive breast cancer in the Chinese Han population. (PMID:23079975)
- Results find ZBTB12 hypomethylation to be linked to shorter TNF-a stimulated whole blood coagulation time and increased WBC and granulocyte counts, further elucidating the possible link between ZBTB12 methylation and cardiovascular disease risk. (PMID:31077224)
- ZBTB12 is a molecular barrier to dedifferentiation in human pluripotent stem cells. (PMID:36759523)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zbtb12.2 | ENSDARG00000070658 |
| danio_rerio | zbtb12.1 | ENSDARG00000103949 |
| mus_musculus | Zbtb12 | ENSMUSG00000049823 |
| rattus_norvegicus | Zbtb12 | ENSRNOG00000071232 |
Paralogs (28): ZNF280C (ENSG00000056277), ZBTB25 (ENSG00000089775), PRDM13 (ENSG00000112238), BCL6 (ENSG00000113916), FEZF1 (ENSG00000128610), ZBTB46 (ENSG00000130584), PRDM12 (ENSG00000130711), ZNF280D (ENSG00000137871), NACC2 (ENSG00000148411), FEZF2 (ENSG00000153266), ZBTB7B (ENSG00000160685), NACC1 (ENSG00000160877), BCL6B (ENSG00000161940), GFI1 (ENSG00000162676), GFI1B (ENSG00000165702), ZBTB49 (ENSG00000168826), ZNF280A (ENSG00000169548), ZNF581 (ENSG00000171425), ZNF524 (ENSG00000171443), ZBTB26 (ENSG00000171448), ZBTB21 (ENSG00000173276), ZNF683 (ENSG00000176083), ZBTB33 (ENSG00000177485), ZBTB3 (ENSG00000185670), ZBTB6 (ENSG00000186130), ZBTB14 (ENSG00000198081), ZNF580 (ENSG00000213015), ZNF280B (ENSG00000275004)
Protein
Protein identifiers
Zinc finger and BTB domain-containing protein 12 — Q9Y330 (reviewed: Q9Y330)
Alternative names: Protein G10
All UniProt accessions (1): Q9Y330
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
RefSeq proteins (1): NP_862825* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050457 | ZnFinger_BTB_dom_contain | Family |
Pfam: PF00096, PF00651
UniProt features (9 total): zinc finger region 4, chain 1, domain 1, region of interest 1, compositionally biased region 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y330-F1 | 57.71 | 0.01 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 19
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 75 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, GOBP_CYTOKINE_PRODUCTION, HNF4_DR1_Q3, PPAR_DR1_Q2, WHN_B, MILI_PSEUDOPODIA_CHEMOTAXIS_UP, MILI_PSEUDOPODIA, E2F1_Q3_01, COUP_DR1_Q6, HNF4ALPHA_Q6, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, BILANGES_SERUM_SENSITIVE_VIA_TSC1
GO Biological Process (3): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of cytokine production (GO:0001817), regulation of immune system process (GO:0002682)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), zinc ion binding (GO:0008270), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleoplasm (GO:0005654), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of transcription by RNA polymerase II | 1 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| cytokine production | 1 |
| regulation of gene expression | 1 |
| regulation of multicellular organismal process | 1 |
| immune system process | 1 |
| regulation of biological process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| transition metal ion binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
648 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZBTB12 | ABHD16A | O95870 | 829 |
| ZBTB12 | PPT2 | Q9UMR5 | 491 |
| ZBTB12 | LTA | P01374 | 459 |
| ZBTB12 | HLA-B | P01889 | 455 |
| ZBTB12 | PRRC2A | P48634 | 448 |
| ZBTB12 | ST6GAL1 | P15907 | 436 |
| ZBTB12 | HLA-C | P04222 | 426 |
| ZBTB12 | SKIC2 | Q15477 | 414 |
| ZBTB12 | PRRT1 | Q99946 | 404 |
| ZBTB12 | DDAH1 | O94760 | 398 |
| ZBTB12 | EBLN2 | Q6P2I7 | 398 |
| ZBTB12 | SPDYE3 | A6NKU9 | 393 |
| ZBTB12 | HSPA1L | P34931 | 388 |
| ZBTB12 | C6orf47 | O95873 | 387 |
| ZBTB12 | RASA1 | P20936 | 382 |
IntAct
15 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZBTB26 | ZBTB12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRB2 | ZBTB12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NCK2 | ZBTB12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB12 | SPTB | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZMYM2 | ZBTB5 | psi-mi:“MI:2364”(proximity) | 0.270 |
| ZMYM2 | TRIM24 | psi-mi:“MI:2364”(proximity) | 0.270 |
| ZBTB12 | ZBTB26 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GRB2 | ZBTB12 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NCK2 | ZBTB12 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (11): SPTB (Affinity Capture-MS), ZBTB12 (Synthetic Lethality), ZBTB12 (Two-hybrid), ZBTB12 (Two-hybrid), ZBTB12 (Two-hybrid), ZBTB12 (Proximity Label-MS), SPTB (Affinity Capture-MS), ZBTB12 (Proximity Label-MS), ZBTB12 (Proximity Label-MS), ZBTB12 (Proximity Label-MS), ZBTB12 (Proximity Label-MS)
ESM2 similar proteins: A0PJY2, A1YPR0, A2A935, B0K011, B0X9H6, B7ZRU9, O13089, O15090, O15156, O75626, O88939, O93567, O95365, P14404, P25932, P41183, P56260, Q03112, Q08DS3, Q0IHB8, Q1L8W0, Q2VWH6, Q32NK7, Q3T135, Q5XJQ7, Q60636, Q64321, Q6AY34, Q6DBW0, Q6F2E4, Q802Y8, Q8I7Z8, Q8K083, Q8N9L1, Q8NAP8, Q8TBJ5, Q8VCZ7, Q8VDL9, Q98T94, Q99PV8
Diamond homologs: A0JN76, A1YPR0, A6QQY2, B1WBS3, B2RXF5, D4A2K4, D4A8X0, F1LZF0, O14867, O15062, O15209, O35260, O43298, O43829, O88282, O88939, O93567, O95198, O95365, O95625, P97303, Q08376, Q08DS0, Q0D2A9, Q0IJ29, Q13105, Q14526, Q1L8W0, Q3B725, Q3B7M1, Q3U410, Q4KLM4, Q503R4, Q52KG4, Q562B4, Q5EXX3, Q5F293, Q5NBY9, Q5TJE2, Q5U374
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| Ub:E2 | “up-regulates activity” | ZBTB12 | ubiquitination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
180 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:31901321:CAACC:C | acceptor_gain | 0.9900 |
| 6:31901322:AACC:A | acceptor_gain | 0.9900 |
| 6:31901323:ACC:A | acceptor_gain | 0.9900 |
| 6:31901324:CC:C | acceptor_gain | 0.9900 |
| 6:31901324:CCC:C | acceptor_gain | 0.9900 |
| 6:31901325:CC:C | acceptor_gain | 0.9900 |
| 6:31901326:C:CC | acceptor_gain | 0.9900 |
| 6:31901327:T:C | acceptor_loss | 0.9900 |
| 6:31901330:T:C | acceptor_gain | 0.9900 |
| 6:31901326:C:T | acceptor_gain | 0.9800 |
| 6:31901329:G:GC | acceptor_gain | 0.9700 |
| 6:31901330:T:TC | acceptor_gain | 0.9700 |
| 6:31901828:T:A | donor_gain | 0.9600 |
| 6:31901329:G:C | acceptor_gain | 0.9400 |
| 6:31901831:TCTCA:T | donor_loss | 0.9300 |
| 6:31901832:CTCA:C | donor_loss | 0.9300 |
| 6:31901833:TCA:T | donor_loss | 0.9300 |
| 6:31901834:CA:C | donor_loss | 0.9300 |
| 6:31901835:ACCT:A | donor_loss | 0.9300 |
| 6:31901836:CC:C | donor_loss | 0.9300 |
| 6:31900665:TC:T | donor_gain | 0.8900 |
| 6:31900666:CC:C | donor_gain | 0.8900 |
| 6:31901423:T:TA | donor_gain | 0.8500 |
| 6:31901904:G:GT | donor_gain | 0.8500 |
| 6:31901449:T:TA | donor_gain | 0.8400 |
| 6:31901431:C:CA | donor_gain | 0.8300 |
| 6:31901913:A:T | donor_gain | 0.8200 |
| 6:31901407:G:A | donor_gain | 0.7900 |
| 6:31901482:C:A | donor_gain | 0.7600 |
| 6:31901837:C:G | donor_loss | 0.7600 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000900895 (6:31899814 C>A), RS1002382850 (6:31899623 T>C,G), RS1002455041 (6:31899328 C>G), RS1003195376 (6:31902427 G>A,C), RS1003228425 (6:31902647 C>A), RS1004753498 (6:31902392 G>A,T), RS1005737557 (6:31899303 C>G), RS1006013712 (6:31903801 G>A), RS1006068207 (6:31903463 C>A), RS1007823757 (6:31904034 AAAAAT>A), RS1009078928 (6:31902298 A>C,G), RS1010489547 (6:31902687 C>T), RS1010791996 (6:31902480 G>T), RS1011614657 (6:31903949 A>G), RS1011647336 (6:31903356 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
27 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001779_12 | Hematology traits | 2.000000e-08 |
| GCST004131_25 | Inflammatory bowel disease | 2.000000e-31 |
| GCST004133_79 | Ulcerative colitis | 5.000000e-65 |
| GCST004521_114 | Autism spectrum disorder or schizophrenia | 3.000000e-17 |
| GCST004521_117 | Autism spectrum disorder or schizophrenia | 3.000000e-15 |
| GCST004521_118 | Autism spectrum disorder or schizophrenia | 3.000000e-15 |
| GCST004521_126 | Autism spectrum disorder or schizophrenia | 2.000000e-10 |
| GCST004521_154 | Autism spectrum disorder or schizophrenia | 3.000000e-08 |
| GCST004521_162 | Autism spectrum disorder or schizophrenia | 3.000000e-08 |
| GCST004521_17 | Autism spectrum disorder or schizophrenia | 2.000000e-12 |
| GCST004521_173 | Autism spectrum disorder or schizophrenia | 4.000000e-14 |
| GCST004521_209 | Autism spectrum disorder or schizophrenia | 5.000000e-16 |
| GCST004521_211 | Autism spectrum disorder or schizophrenia | 5.000000e-15 |
| GCST004521_213 | Autism spectrum disorder or schizophrenia | 5.000000e-13 |
| GCST004521_224 | Autism spectrum disorder or schizophrenia | 5.000000e-10 |
| GCST004521_227 | Autism spectrum disorder or schizophrenia | 4.000000e-12 |
| GCST004521_296 | Autism spectrum disorder or schizophrenia | 6.000000e-18 |
| GCST004521_45 | Autism spectrum disorder or schizophrenia | 2.000000e-16 |
| GCST004521_70 | Autism spectrum disorder or schizophrenia | 8.000000e-20 |
| GCST004521_81 | Autism spectrum disorder or schizophrenia | 1.000000e-14 |
| GCST005790_63 | Rosacea symptom severity | 7.000000e-11 |
| GCST008916_30 | Asthma | 1.000000e-09 |
| GCST012276_6 | Clostridioides difficle infection in antibiotics-users | 1.000000e-06 |
| GCST012277_23 | Clostridioides difficle infection | 4.000000e-06 |
| GCST90020024_1060 | A body shape index | 2.000000e-11 |
| GCST90020025_515 | Waist-to-hip ratio adjusted for BMI | 2.000000e-11 |
| GCST90020027_762 | Waist-hip index | 5.000000e-11 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009180 | rosacea severity measurement |
| EFO:0009130 | clostridium difficile infection |
| EFO:0007789 | BMI-adjusted waist circumference |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| bisphenol A | increases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| sodium arsenite | decreases expression, increases abundance | 1 |
| jinfukang | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| 8-Bromo Cyclic Adenosine Monophosphate | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Acrylamide | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XV86 | HEK293 eGFP-ZBTB12 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.